117 related articles for article (PubMed ID: 34310951)
21. NCAPG2 contributes to the progression of malignant melanoma through regulating proliferation and metastasis.
Feng Z; Zhang L; Liu Y; Zhang W
Biochem Cell Biol; 2022 Dec; 100(6):473-484. PubMed ID: 36265182
[TBL] [Abstract][Full Text] [Related]
22. Geranylnaringenin (CG902) inhibits constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase.
Jin Y; Yoon YJ; Jeon YJ; Choi J; Lee YJ; Lee J; Choi S; Nash O; Han DC; Kwon BM
Biochem Pharmacol; 2017 Oct; 142():46-57. PubMed ID: 28666623
[TBL] [Abstract][Full Text] [Related]
23. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
Nat Commun; 2013; 4():1508. PubMed ID: 23443536
[TBL] [Abstract][Full Text] [Related]
24. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A.
Su T; Wang YP; Wang XN; Li CY; Zhu PL; Huang YM; Yang ZY; Chen SB; Yu ZL
Life Sci; 2020 Jan; 241():117169. PubMed ID: 31843524
[TBL] [Abstract][Full Text] [Related]
25. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of miR-1280 in melanoma by regulation of Src.
Sun V; Zhou WB; Nosrati M; Majid S; Thummala S; de Semir D; Bezrookove V; de Feraudy S; Chun L; Schadendorf D; Debs R; Kashani-Sabet M; Dar AA
Mol Ther; 2015 Jan; 23(1):71-8. PubMed ID: 25195599
[TBL] [Abstract][Full Text] [Related]
27. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
[TBL] [Abstract][Full Text] [Related]
28. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
29. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
[TBL] [Abstract][Full Text] [Related]
30. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
[TBL] [Abstract][Full Text] [Related]
31. Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells.
Furcht CM; Buonato JM; Skuli N; Mathew LK; Muñoz Rojas AR; Simon MC; Lazzara MJ
J Cell Sci; 2014 Aug; 127(Pt 16):3555-67. PubMed ID: 24951116
[TBL] [Abstract][Full Text] [Related]
32. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
Yu SJ; Long ZW
Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis.
Zhao F; Jia Z; Feng Y; Li Z; Feng J
J Dermatol Sci; 2021 Apr; 102(1):7-15. PubMed ID: 33648800
[TBL] [Abstract][Full Text] [Related]
34. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
35. Regulation of eIF2α by RNF4 Promotes Melanoma Tumorigenesis and Therapy Resistance.
Avitan-Hersh E; Feng Y; Oknin Vaisman A; Abu Ahmad Y; Zohar Y; Zhang T; Lee JS; Lazar I; Sheikh Khalil S; Feiler Y; Kluger H; Kahana C; Brown K; Ruppin E; Ronai ZA; Orian A
J Invest Dermatol; 2020 Dec; 140(12):2466-2477. PubMed ID: 32360601
[TBL] [Abstract][Full Text] [Related]
36. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.
Su F; Ren F; Rong Y; Wang Y; Geng Y; Wang Y; Feng M; Ju Y; Li Y; Zhao ZJ; Meng K; Chang Z
Breast Cancer Res; 2012 Mar; 14(2):R38. PubMed ID: 22394684
[TBL] [Abstract][Full Text] [Related]
38. lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma.
Mou K; Liu B; Ding M; Mu X; Han D; Zhou Y; Wang LJ
Int J Oncol; 2018 Sep; 53(3):1094-1104. PubMed ID: 29956757
[TBL] [Abstract][Full Text] [Related]
39. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
[TBL] [Abstract][Full Text] [Related]
40. EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.
Tiffen J; Gallagher SJ; Filipp F; Gunatilake D; Emran AA; Cullinane C; Dutton-Register K; Aoude L; Hayward N; Chatterjee A; Rodger EJ; Eccles MR; Hersey P
J Invest Dermatol; 2020 Dec; 140(12):2442-2454.e5. PubMed ID: 32360600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]